Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications
Published Online: 2024-03-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Atse H Huisman•Edwin van Breugel•Gabe S Sonke•Hans M Westgeest•Lonneke Timmers•Sahar Barjesteh van Waalwijk van Doorn-Khosrovani•Simone N Koole
